Data Sharing

Research findings, biological material resources and tools generated by the work of this Conte Center will be disseminated to the scientific community and lay public as extensively and as rapidly as possible. The major form of disseminating information to the scientific community is likely to be via research publications. Research findings will also be disseminated via scientific presentations by our faculty and fellows at scientific meetings and research seminars.

FY 2013/2014

May 2013

Paul Greengard, Center Director, was the Keynote Speaker for the MIT Picower Institute Symposium, May 16, Boston, MA.

Paul Greengard, Center Director, spoke for the Memorial Sloan-Kettering Cancer Center President’s Research Seminar Series, May 29, New York, NY.

Eric Nestler, Project 4 Leader, was invited to speak May 6-7, 2013 on the Epigenetic Mechanisms in Psychiatry, Conference on Epigenetics, University of Virginia, Charlottesville, VA.

Eric Nestler, Project 4 Leader, participated in a Roundtable Discussion: Resilience and gave the Presidential Plenary Lecture: Neurobiology of Depression, for the American Psychiatric Association Annual Meeting, May 21, 2013, San Francisco, CA.

Jim Surmeier, Project 5 Leader, was a speaker May 15 &16, 2013 for the NIH/NIAAA Seminar, Rockville, MD.

Jim Surmeier, Project 5 Leader, spoke for the 4th Biennial Workshop on Circuit and Pathways in Dystonia and Parkinsonism, Monte Porzio Catone, Rome, Italy, May 31 – June 1, 2013.

June 2013

Paul Greengard, Center Director, spoke for the Drug and Discovery and Therapy World Congress, June 3-6, 2013, Cambridge, MA.

Jim Surmeier, Project 5 Leader, for the 17th International Congress of Parkinson's Disease and Movement Disorders, Sydney, Australia, June 16-20, 2013.

Paul Greengard, Center Director, was the invited speaker for “A Nobel Day” conference June 25, in Lisbon, Portugal.

July 2013

Angus Nairn, Project 3 Leader, presented a talk entitled “Beyond the Dopamine Receptor: Regulation and Roles of Serine/Threonine Protein Phosphatases” at the EMBO meeting on EuroPhosphatases, July 9, 2013, Rehovot, Israel.

Angus Nairn, Project 3 Leader, presented a talk entitled “Proteomics of Dopamine Signaling”July 29, 2013 at Mount Sinai School of Medicine, New York, NY.

August 2013

Angus Nairn, Project 3 Leader, presented a talk entitled “Cellular and Molecular Mechanisms of Addiction: Signal Transduction Mechanisms Beyond the Dopamine Receptor” for the Course on the "CELLULAR BIOLOGY OF ADDICTION" August 9, 2013, Cold Spring Harbor, NY.

September 2013

Eric Nestler, Project 4 Leader, was Scientific Host for the Staglin Music Festival for Mental Health, Rutherford, CA, September 7, 2013.

Paul Greengard, Center Director, spoke for the Symposium for Rodolfo Llinas, Brain Meets Cognition, September 10, New York, NY.

October 2013

Paul Greengard, Center Director, spoke at the Simons Center for Systems Biology, October 8, 2013, Princeton, NJ.

Angus Nairn, Project 3 Leader, presented a talk entitled “Proteomics of Dopamine Signaling” October 8, 2013 at the Albert Einstein School of Medicine, New York, NY.

Paul Greengard, Center Director, was invited to speak at the Lieber Institute at Johns Hopkins University, Baltimore, MD.

Eric Nestler, Project 4 Leader, was invited to speak on the Epigenetic Contributions to Psychiatric Illness, Xijing Medical Center, XiAn, China, October 24, 2013.

November 2013

Eric Nestler, Project 4 Leader, was invited to speak on the Neurobiology of Depression, Peking University, Beijing, China, November 1, 2013.

Angus Nairn, Project 3 Leader, presented a talk entitled “Beyond the Dopamine Receptor: Regulation and Roles of Serine/Threonine Protein Phosphatases” for the Yale-Cajal joint symposium November 6, 2013, New Haven, CT.

Eric Nestler, Project 4 Leader, was invited to speak on the Optogenetic Approaches in Psychiatry, Symposium on Circuit and Network Analysis, 2013 Annual Meeting of the Society for Neuroscience, San Diego, CA.

December 2013

Angus Nairn, Project 3 Leader, presented a talk entitled Organizer and Discussion leader at the FNIH Biomarkers Consortium CSF Proteomics Workshop December 5-7, 2013, Bethesda, MD.

Eric Nestler, Project 4 Leader, spoke on the Epigenetic Mechanisms in Psychiatry, at the Symposium at the Annual Meeting of the American College of Neuropsychopharmacology, Hollywood, FL, December 11, 2013.

January 2014

Eric Nestler, Project 4 Leader received the Special Achievement Award at the 2014 Miami Winter Symposium, Miami FL and gave a Lecture: Transcriptional and Epigenetic Mechanisms of Addiction, January 27, 2014.

February 2014

Eric Nestler, Project 4 Leader, gave a talk on the Epigenetic Mechanisms of Depression, Symposium on Epigenetic Mechanisms in Brain Diseases, UC Irvine, Irvine, CA, February 21, 2014.

March 2014

Eric Nestler, Project 4 Leader, was invited to present a talk: New Approaches to the Study of Mental Illness, for the Samuel B. Guze Lecture in the Department of Psychiatry, March 18, 2014 at Washington University, St. Louis, MO.

Paul Greengard, Center Director, was invited to be the Keynote Speaker for the Dopamine and the Brain Symposium, NY, NY.

April 2014

Eric Nestler, Project 4 Leader, was invited to present a talk: Epigenetic Mechanisms of Depression, April 25, 2014 at the University of Calgary, Calgary, CA.

FY 2012/2013

March 2012

Anne Schaefer, Animal Core Leader, presented a talk on Eurkaryotic Transciption (Z2) at the Keystone Symposia March 31 – April 5, 2012, Snowbird, UT.

May 2012

Paul Greengard, Center Director, was invited to speak as a panelist for the Alexandria Center for Life Science May 3-4, 2012. The topic of the panel was "Translating Innovation into New Approaches for Neuroscience - How and when will we discover the next generations?" New York, NY.

Anne Schaefer, Animal Core Leader, was invited to speak for the Gordon Conference on Chromatin Structure and Function May 6-11, 2012, Barga, Italy.

Jim Surmeier, Project 5 Leader, was invited speaker May 7, 2012 for the 2nd Annual ALS Symposium, Chicago, IL.

Nat Heintz, Project 2 Leader, was invited to speak May 10, 2012 on Molecular Mechanisms Controlling the Specialized Properties of CNS Cell Types in Health and Disease for the Neuroscience Seminar Series at

Johns Hopkins University, Baltimore, MD.

Jim Surmeier, Project 5 Leader, participated May 16-18, 2012 in the Gladstone-DZNE Workshop, Bonn, Germany.

Paul Greengard, Center Director, was the Keynote Speaker May 17-18, 2012 for the Global Health and the Arts 2012 Symposium at the Longacre Theater at Yale University, New Haven, CT.

Jim Surmeier, Project 5 Leader, was Plenary Speaker May 20-23, 2012 for the Canadian Association for Neuroscience.

June 2012

Jim Surmeier, Project 5 Leader, was invited speaker June 5-7, 2012 for the CHDI Working Group, Los Angeles, CA.

Jim Surmeier, Project 5 Leader, was invited speaker June 17 for the 16th International Congress of Parkinson’s Disease and Movement Disorders, Dublin, Ireland.

Jim Surmeier, Project 5 Leader, was invited speaker June 27, 2012 for the Neurological Sciences and Disorders meeting in San Francisco, CA.

July 2012

Paul Greengard, Center Director, and Jim Surmeier, Project 5 Leader, participated in the JPB Foundation Parkinson’s Disease Consortium Summer Meeting, July 17-18,2012, New York, NY.

Angus Nairn, Project 3 Leader, was invited to speak July 18-25, 2012 on “Signal Transduction Mechanisms Beyond the Dopamine Receptor” as part of the "Cellular Biology of Addiction" summer course, a partnership between Cold Spring Harbor Laboratory and the Barcelona Biomedical Research Park (PRBB), Barcelona, Spain.

The lecture is available on-line as a pdf and a video at the link:
http://www.upf.edu/neurophar/actualitat/videos.html
http://www.upf.edu/neurophar/_pdf/16_Nairn_Addiction_Barcelona_23_July_2012.pdf

September 2012

Jim Surmeier, Project 5 Leader, participated September 9-13, 2012 in the 10th International Catecholamine Symposium, Pacific Grove, CA

Jim Surmeier, Project 5 Leader, was invited speaker September 9-13, 2012 at Boston University, Boston, MA.

Nat Heintz, Project 2 Leader, was invited to speak September 18, 2012 on Beyond Brain Circuitry: Molecular Mechanisms Controlling the Specialized Properties of CNS Cell Types in Health and Disease for the Ruth K. Broad and Shepard Broad Foundation Seminar Series on Neurobiology and Disease
Duke University Medical Center, Durham, NC.

Eric Nestler, Project 4 Leader, was Course Director September 22-29, 2012 for the Neuroscience School of Advanced Studies, Epigenetic and Circuit Mechanisms of Depression, San Quirico D’Orcia, Italy.

October 2012

Jim Surmeier, Project 5 Leader, participated October 10-12, 2012 in the Cell Symposia Neuromodulatory meeting, at the SFN, New Orleans, LA.

Eric Nestler, Project 4 Leader, was invited speaker October 11, 2012 for a talk entitled Role of BDNF-TrkB Signaling in the VTA-NAc Circuit, for the SFN Pre-Meeting on Optogenetics, New Orleans, LA.

Eric Nestler, Project 4 Leader, was invited speaker October 12, 2012, for a talk entitled Analysis of Gene Expression and Chromatin Data in Drug Abuse Models, for the SFN Pre-Meeting on Transcriptomics, New Orleans, LA.

Angus Nairn, Project 3 Leader, was Keynote Speaker October 12, 2012 at the Society for Neuroscience Satellite Meeting on "Phosphatases in Neuroscience". His talk was entitled "Beyond the Dopamine Receptor: Role and Regulation of Serine/Threonine Protein Phosphatases." New Orleans, LA.

Eric Nestler, Project 4 Leader participated in the Meet the Expert Panel, October 13, 2012, at SFN, New Orleans, LA.

Jim Surmeier, Project 5 Leader, participated October 21-23, 2012 in The Bachmann Strauss Think Tank, New York, NY.

Nat Heintz, Project 2 Leader, was invited to speak October 25, 2012 on Molecular Mechanisms Controlling the Specialized Properties of CNS Cell Types in Health and Disease for the MIT Colloquium Series on the Brain and Cognition at the Picower Institute, Cambridge, MA.

November 2012

Eric Nestler, Project 4 Leader, was invited speaker November 6, 2012 for a talk entitled Epigenetic Mechanisms of Drug Addiction, for the 10th Anniversary Celebration of the Picower Institute, MIT, Cambridge, MA.

Angus Nairn, Project 3 Leader, was invited to speak, Nov 12, 2013, and presented  “Beyond the Dopamine Receptor: Regulation and Function of Serine/Threonine Protein Phosphatases” for the Department of Biochemistry and Molecular Biology,  University of Texas Medical School,  Houston, Tx.

Eric Nestler, Project 4 Leader, participated in Talk to the Public: Current Research in Depression, at Annual Hope for Depression Research Foundation Seminar, New York, NY on November 12, 2012.

Jim Surmeier, Project 5 Leader, participated November 12, 2012 in a seminar at Merck Research Laboratories in New Jersey.

Eric Nestler, Project 4 Leader, was invited speaker November 24, 2012 for a talk entitled New Insight into the Biology of Depression, Anna Monika Foundation Symposium, World Psychiatric Congress, Berlin, Germany.

December 2012

Eric Nestler, Project 4 Leader, was invited speaker for a talk entitled Dendritic Plasticity in Drug Addiction, Panel at American College of Neuropsychopharmacology, Hollywood, FL December 6, 2012.

Anne Schaefer, Animal Core Leader, was invited to speak for the 51st ACNP Annual Meeting, Hollywood, FL December 6, 2012.

January 2013

Jim Surmeier, Project 5 Leader, participated January 19, 2013 in the Gordon Research Conference Chair Training Session, Boston, MA.

February 2013

Eric Nestler, Project 4 Leader, was Panel Moderator February 1, 2013 for Translational Research in Depression, at Innovations in Psychiatry Symposium, Mount Sinai Medical Center, New York, FL.

Eric Nestler, Project 4 Leader, was invited speaker February 5, 2013 for a talk entitled Transcriptional and Epigenetic Mechanisms of Addiction, University of Colorado, Department of Psychology and Behavioral Neuroscience, Boulder, CO.

Eric Nestler, Project 4 Leader, was invited speaker February 14, 2013 for a talk entitled New Insight into the Biology of Depression, New York University, Department of Psychiatry, New York, NY.

Jim Surmeier, Project 5 Leader, participated February 20, 2013 in a seminar at Johns Hopkins University, Baltimore, MD.

Jim Surmeier, Project 5 Leader, participated February 22, 2013 in a seminar at Rosalind Franklin University, North Chicago, IL.

March 2013

Eric Nestler, Project 4 Leader, was invited speaker March 1, 2013 for a talk entitled Transcriptional and Epigenetic Mechanisms of Addiction, Baylor Medical College, Department of Neuroscience, Houston, TX.

Eric Nestler, Project 4 Leader, was invited speaker March 4, 2013 for Talk to the Public: New Tools of Neuroscience, at Annual Bachmann-Strauss Foundation Seminar, New York, NY.

April 2013

Eric Nestler, Project 4 Leader, was invited to speak April 3, 2013 on the Transcriptional and Epigenetic Mechanisms of Addiction, University of Massachusetts School of Medicine, Department of Neuroscience, Worcester, MA.

Eric Nestler, Project 4 Leader, was invited to speak April 5, 2013 for the Plenary Lecture: Biology of Brain Reward Systems, at the American Neuropsychiatric Association Annual Meeting, Boston, MA.

Jim Surmeier, Project 5 Leader, was invited to speak April 4-11, 2013 for the CHDI Foundation’s 8th Annual Huntington’s Disease Therapeutic Conference, Venice, Italy.

Jim Surmeier, Project 5 Leader, was invited to speak on Understanding Parkinson’s Disease: Cell Vulnerability and Disease Progression April 11-13, 2013, Pamploma, Spain.

Jim Surmeier, Project 5 Leader, was invited to speak on the Functional Genomics of Parkinson’s Disease and Beyond April 18-21, 2013, Tubingen, Germany.

Eric Nestler, Project 4 Leader, was invited to speak April 22, 2013 for the Plenary Lecture: Epigenetic Mechanisms of Addiction: Lessons for Schizophrenia Research, at the International Congress on Schizophrenia, Orlando, FL.

FY 2011/2012

January 2012

Angus Nairn, Project 3 Leader, was an invited speaker at the Kavli Foundation workshop on "Development of molecular genetic methods to probe neuronal function", Yale University, New Haven, CT, January 31, 2012. Lecture title - BAC transgenic mice for targeted proteomics.

December 2011

Eric Nestler, Project 4 Leader, was a Symposium Chair for the ACNP Symposium on Psychiatric Drug Discovery, Hawaii, HI, December 5, 2011.

November 2011

Nat Heintz, Project 2 Leader, spoke at NIH/NINDS, Bethesda, MD, November 11, 2011. Lecture title - Setting Priorities for Neuroanatomy for the Next Generation.

Jim Surmeier, Project 5 Leader, spoke at Eli Lilly, Indianapolis, IN, November 16-17, 2011. Lecture title - Calcium Channels, Metabolic Stress and Parkinson's Disease.

Anne Schaefer, Animal Core Leader, spoke for the Seaver Autism Center Meeting, November 29, 2011 at the Seaver Foundation, Mount Sinai School of Medicine, NY, NY. Lecture title - Epigenetic regulation in Autism.

October 2011

Eric Nestler, Project 4 Leader, spoke for the UAB Comprehensive Neuroscience Center Symposium, Birmingham, AL, October 4, 2011. Lecture title - Epigenetic Mechanisms of Psychotropic Drug Action.

Jim Surmeier, Project 5 Leader, spoke at the University of Washington, Tacoma, WA, October 9-11, 2011. Lecture title - Dopaminergic Modulation of Dendritic Excitability and Synaptic Plasticity in the Striatum.

Angus Nairn, Project 3 Leader, gave a seminar presentation at Princeton University, Princeton, NJ, October 19, 2011. Seminar title - Beyond the dopamine receptor: Regulation and roles of Serine/Threonine Protein Phosphatases.

Eric Nestler, Project 4 Leader, spoke at Hoshi University, Tokyo, Japan, October 27, 2011. Lecture title - Epigenetic Adaptations in Striatum.

Paul Greengard, Center Director, was an invited speaker for the Johnson & Johnson Neuroscience One Team Meeting, October 27-28, 2011 in Jersey City, NJ. Lecture title - Novel Approaches to the Understanding and Treatment of Neuropsychiatric and Neurological Disorders.

Jim Surmeier, Project 5 Leader, for the Developmental Disturbances in the Nervous System Conference, Berlin, Germany, October 26-29, 2011. Lecture title - What makes neurons vulnerable in Parkinson's disease?

September 2011

Jim Surmeier, Project 5 Leader, spoke in San Quirico d'Orcia, Italy September 17-20, 2011. Lecture title - Brain Networks in Huntington's and Parkinson's disease.

August 2011

Anne Schaefer, Animal Core Leader, spoke on epigenetic suppression in adult brain function for the FASEB summer conference on Epigenetic, Chromatin, and Transcription, Snowmass Colorado, USA July 31- August 5th, 2011.

Angus Nairn, Project 3 Leader, was an invited lecturer for the Cold Spring Harbor course on Cellular Biology of Addiction, Cold Spring, NY, August 13, 2011. Lecture title - Beyond the Dopamine Receptor: Signal Transduction Mechanisms.

Nat Heintz, Project 2 Leader, spoke at the Allen Institute, Seattle, WA, August 31, 2011. Lecture title - Genetic Dissection of the Mouse Brain: Toward a 21st Century Brain Pharmacology.

July 2011

Jim Surmeier, Project 5 Leader, spoke at the Columbia University Liever Center, NY, NY, July 5-6, 2011. Lecture title - Dopaminergic Modulation of Striatal Dendritic Integration and Synaptic Plasticity.

Angus Nairn, Project 3 Leader, was an invited speaker at the EMBO conference on Europhosphatases, Baden, Vienna, Austria, July 20, 2011. Lecture title - Beyond the dopamine receptor: Regulation and roles of Serine/Threonine Protein Phosphatases.

June 2011

Nat Heintz, Project 2 Leader, for the Fourth Weissenburg Symposium, EPIGENETICS 2011, Weissenburg, Germany, June 20-22, 2011. Lecture title - 5-Hydroxymethylcytosine, Neurons and Nuclear Function.

Angus Nairn, Project 3 Leader, was an invited speaker at the Jacobaeus Symposium, Oslo, Norway, June 21, 2011. Lecture title - Beyond the dopamine receptor: Regulation and roles of Serine/Threonine Protein Phosphatases.

May 2011

Angus Nairn, Project 3 Leader, was an invited speaker at the Annual Meeting of the Korean Society for Biochemistry and Molecular Biology, Seoul, Korea, May 18, 2011. Lecture title - Beyond the dopamine receptor: Regulation and roles of Serine/Threonine Protein Phosphatases.

April 2011

Anne Schaefer, Animal Core Leader, was an invited speaker for the Epigenetics, Brain, Behavior meeting from the Ipsen Fondation, Paris, France,April 18th 2011. Lecture title - Control of Gene Transcription and Behavior by the Epigenetic Suppressor Complex G9a/GLP.

February 2011

Nat Heintz, Project 2 Leader, spoke for the UCSD CMM\LICR Seminar Series, San Diego, CA, February 10, 2011. Lecture title - Addressing Brain Complexity.

January 2011

Anne Schaefer, Animal Core Leader, was an invited speaker at the 44th Winter Conference on Brain Research, Keystone, CO, January 23-27, 2011. Lecture title - miR128 Controls Dopamine Regulated Behavior in Mice.

FY 2010/2011

September 2010

Paul Greengard, Center Director, was a panel leader for the Prix Galien Forum on Translational Neuroscience: Academic-Industrial Collaborations in CNS Diseases and the opening of the Alexandria Center for Life Sciences, NYC. http://www.alexandrianyc.com/

October 2010

Paul Greengard, Center Director, was an invited speaker for the Clinical Scholar's Program of Rockefeller University. He discussed the research of the Conte Center and shared thoughts about translational opportunities that stem from lab discoveries. http://www.rockefeller.edu/ccts/

Eric Nester, Project 4 Leader, Invited Speaker - NYAS Conference on Behavioral Epigenetics, Boston MA. Lecture Title - Epigenetics: Basic Processes and Mechanisms

D. James Surmeier, Project 5 Leader, Invited Speaker, Yale School of Medicine Cellular Neuroscience, neurodegeneration and Repair Seminar. Lecture Title - Dopaminergic control of striatal excitability and synaptic plasticity. http://medicine.yale.edu/cnnr/index.aspx

December 2010

Eric Nester, Project 4 Leader, Invited Speaker - ACNP Annual Meeting, Miami, FL Lecture Title - Compound screening for small molecule modulators of the transcription factor, δFosB

March 2011

Paul Greengard, Center Director, was the invited speaker for the Rockefeller University Head of Laboratories Forum. Lecture title-Tales of Two Maladies: Alzheimer's Disease and Depression.

Eric Nester, Project 4 Leader, Keynote Speaker - New York Academy of Sciences Meeting on Advancing Drug Discovery for Schizophrenia. Lecture Title - What can we learn from animal models of schizophrenia? http://www.nyas.org/Events/Detail.aspx?cid=55938b51-f0d8-4d2b-aab7-de7436c96440

Project Leaders